REDWOOD CITY, Calif.--(BUSINESS WIRE)--Genelabs Technologies, Inc. (Nasdaq:GNLB) announced today that it has entered into a collaborative research agreement with the National Health Research Institutes (NHRI), a non-profit foundation established by the government of the Republic of China, and Genovate Biotechnology Co., Ltd. (Genovate) a fully integrated biopharmaceutical company in Taiwan. The intent of the collaboration between the three parties is to jointly conduct further research to discover and develop compounds that target the hepatitis C virus (HCV).
